Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.2B | 5.1B | 5.2B | 5.2B |
Cost of revenue | 2.8B | 2.8B | 2.8B | 2.8B |
Gross profit | 2.4B | 2.3B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | -11.1M | — | — |
Other operating expenses | 272.0M | 306.2M | 239.6M | 301.9M |
Operating income | 2.2B | 2.0B | 2.2B | 2.1B |
Non operating interest income | ||||
Income | 13.6M | — | 44.3M | 0 |
Expense | 285.7M | 274.6M | 266.1M | 267.8M |
Other income expense | 91.2M | 66.5M | 13.6M | 74.2M |
Pretax income | 2.0B | 1.8B | 1.9B | 1.9B |
Tax provision | 372.7M | 427.3M | 442.6M | 441.8M |
Net income | 1.6B | 1.4B | 1.5B | 1.4B |
Basic EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Basic average shares | 6.8B | 6.8B | 6.9B | 6.9B |
Diluted average shares | 6.8B | 6.9B | 6.9B | 6.9B |
EBITDA | 2.8B | 2.6B | 2.7B | 2.6B |
Net income from continuing op. | 1.6B | 1.4B | 1.5B | 1.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |